Package 65162-212-10

{"route": ["ORAL"], "spl_id": "2b4f7d43-b5df-46e4-9cb9-216b70a360a0", "openfda": {"upc": ["0365162212037", "0365162212105"], "unii": ["4182431BJH"], "rxcui": ["855671"], "spl_set_id": ["7e467c02-49a0-4b62-b537-430fdfa4f10e"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (65162-212-03)", "package_ndc": "65162-212-03", "marketing_start_date": "20091216"}, {"sample": false, "description": "100 CAPSULE in 1 BOTTLE (65162-212-10)", "package_ndc": "65162-212-10", "marketing_start_date": "20091216"}, {"sample": false, "description": "1000 CAPSULE in 1 BOTTLE (65162-212-11)", "package_ndc": "65162-212-11", "marketing_start_date": "20091216"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (65162-212-50)", "package_ndc": "65162-212-50", "marketing_start_date": "20091216"}], "brand_name": "Extended Phenytoin Sodium", "product_id": "65162-212_2b4f7d43-b5df-46e4-9cb9-216b70a360a0", "dosage_form": "CAPSULE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "65162-212", "generic_name": "Phenytoin Sodium", "labeler_name": "Amneal Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Extended Phenytoin Sodium", "active_ingredients": [{"name": "PHENYTOIN SODIUM", "strength": "100 mg/1"}], "application_number": "ANDA040765", "marketing_category": "ANDA", "marketing_start_date": "20091216", "listing_expiration_date": "20261231"}